Cited by 6Genetics, Aging, and Longevity in Model OrganismsMuscle Physiology and DisordersNutrition and Health in Aging

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans

Open access

Published version of a preprint

Abstract

Sarcopenia is the age-related degeneration of skeletal muscle, resulting in loss of skeletal muscle tone, mass, and quality. Skeletal muscle is a source of systemic metabolites and macromolecules important for neuronal health, function, and healthy neuronal aging. Age-related loss of skeletal muscle might result in decreased metabolite and macromolecule availability, resulting in reduced neuronal function or increased susceptibility to unhealthy aging and neurodegenerative diseases. We aimed to identify muscle metabolite candidates that regulate healthy aging. C57BL/6J mice were aged to young adult (4 months) and old age (25 months) and skeletal muscle was collected. Age-related muscle loss was confirmed by reduced muscle mass, muscle fiber degeneration, reduced myosin intensity, in addition to a metabolic shift and increased DNA damage in skeletal muscle. Using a low molecular weight enriched metabolomics protocol, we assessed the metabolic profile of skeletal muscle from young adult and old age mice and identified 20 metabolites that were significantly changed in aged muscle. These metabolite candidates were tested in C. elegans assays of lifespan, healthspan, muscle, and mitochondrial morphology under normal and stressed conditions. We identified four metabolite candidates (beta-alanine, 4-guanidinobutanoic acid, 4-hydroxyproline, pantothenic acid) that, when supplemented in C. elegans provided robust gero- and mitochondrial protection. These candidates also affected life-, and health- span in C. elegans models of amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD). Our findings support that aging muscle can be used to identify novel metabolite modulators of lifespan and health and may show promise for future treatments of neurodegenerative and neuromuscular disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.redox.2025.103732

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Börsch, 2021, Molecular and phenotypic analysis of rodent models reveals conserved and species-specific modulators of human sarcopenia, Commun. Biol., 4, 194, 10.1038/s42003-021-01723-z · DOI · Paper page
  2. Uchitomi, 2019, Metabolomic analysis of skeletal muscle in aged mice, Sci. Rep., 9, 10.1038/s41598-019-46929-8 · DOI
  3. Granic, 2023, Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men, Clin. Sci. (Lond.), 137, 1721, 10.1042/CS20230319 · DOI
  4. Widjaja, 2024, Inhibition of IL-11 signalling extends mammalian healthspan and lifespan, Nature, 632, 157, 10.1038/s41586-024-07701-9 · DOI · Paper page
  5. Lexell, 1988, What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men, J. Neurol. Sci., 84, 275, 10.1016/0022-510X(88)90132-3 · DOI
  6. Cruz-Jentoft, 2019, Sarcopenia: revised European consensus on definition and diagnosis, Age Ageing, 48, 16, 10.1093/ageing/afy169 · DOI · Paper page
  7. Florin, 2020, The secretome of skeletal muscle cells: a systematic review, Osteoarthr Cartil Open, 2, 10.1016/j.ocarto.2019.100019 · DOI
  8. Shen, 2023, Exercise for sarcopenia in older people: a systematic review and network meta-analysis, J Cachexia Sarcopenia Muscle, 14, 1199, 10.1002/jcsm.13225 · DOI · Paper page
  9. Morcillo-Losa, 2024, Effects of high-intensity interval training on muscle strength for the prevention and treatment of Sarcopenia in older adults: a systematic review of the literature, J. Clin. Med., 13, 10.3390/jcm13051299 · DOI
  10. Crowston, 2023, "Doctor, what else can I do for my glaucoma?" Exercise, nicotinamide and other lifestyle interventions, Clin. Exp. Ophthalmol., 51, 289, 10.1111/ceo.14241 · DOI
  11. Tribble, 2021, Targeting diet and exercise for neuroprotection and neurorecovery in glaucoma, Cells, 10, 10.3390/cells10020295 · DOI
  12. Ahlskog, 2011, Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging, Mayo Clin. Proc., 86, 876, 10.4065/mcp.2011.0252 · DOI · Paper page
  13. Liu, 2023, Advances in nutritional supplementation for sarcopenia management, Front. Nutr., 10
  14. Lanznaster, 2022, Metabolomics as a crucial tool to develop new therapeutic strategies for neurodegenerative diseases, Metabolites, 12, 10.3390/metabo12090864 · DOI
  15. Parkhitko, 2020, Targeting metabolic pathways for extension of lifespan and healthspan across multiple species, Ageing Res. Rev., 64, 10.1016/j.arr.2020.101188 · DOI
  16. Wallace, 2018, Relationship between frailty and Alzheimer's disease biomarkers: a scoping review, Alzheimer's Dement., 10, 394
  17. Christian, 2020, Animal models of sarcopenia, Aging Cell, 19, 10.1111/acel.13223 · DOI · Paper page
  18. Xie, 2021, Mouse models of sarcopenia: classification and evaluation, J Cachexia Sarcopenia Muscle, 12, 538, 10.1002/jcsm.12709 · DOI
  19. Biltz, 2017, A novel method for the quantification of fatty infiltration in skeletal muscle, Skeletal Muscle, 7, 1, 10.1186/s13395-016-0118-2 · DOI
  20. Goodpaster, 2023, Intermuscular adipose tissue in metabolic disease, Nat. Rev. Endocrinol., 19, 285, 10.1038/s41574-022-00784-2 · DOI
  21. Zancanaro, 2007, Physical training is associated with changes in nuclear magnetic resonance and morphometrical parameters of the skeletal muscle in senescent mice, Eur. J. Histochem., 51, 305, 10.4081/1156 · DOI
  22. Frontera, 2012, Aging of human muscle: understanding sarcopenia at the single muscle cell level, Phys. Med. Rehabil. Clin, 23, 201, 10.1016/j.pmr.2011.11.012 · DOI · Paper page
  23. Blaauw, 2013, Mechanisms modulating skeletal muscle phenotype, Compr. Physiol., 3, 1645, 10.1002/j.2040-4603.2013.tb00534.x · DOI
  24. Baker, 2010, Interaction among skeletal muscle metabolic energy systems during intense exercise, J Nutr Metab, 2010, 10.1155/2010/905612 · DOI
  25. Misgeld, 2017, Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture, Neuron, 96, 651, 10.1016/j.neuron.2017.09.055 · DOI
  26. Coen, 2018, Mitochondria as a target for mitigating sarcopenia, Front. Physiol., 9, 1883, 10.3389/fphys.2018.01883 · DOI
  27. Srinivasan, 2012, Cytochrome c oxidase dysfunction in oxidative stress, Free Radic. Biol. Med., 53, 1252, 10.1016/j.freeradbiomed.2012.07.021 · DOI
  28. Barron, 2005, Cytochrome c oxidase deficient muscle fibres: substantial variation in their proportions within skeletal muscles from patients with mitochondrial myopathy, Neuromuscul. Disord., 15, 768, 10.1016/j.nmd.2005.06.018 · DOI
  29. Goetzman, 2023, Complex II biology in aging, health, and disease, Antioxidants (Basel), 12
  30. Tribble, 2021, Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction, Redox Biol., 43, 10.1016/j.redox.2021.101988 · DOI
  31. Brenner, 1974, The genetics of Caenorhabditis elegans, Genetics, 77, 71, 10.1093/genetics/77.1.71 · DOI
  32. Olsen, 2006, Using Caenorhabditis elegans as a model for aging and age-related diseases, Ann. N. Y. Acad. Sci., 1067, 120, 10.1196/annals.1354.015 · DOI
  33. Scharf, 2021, Reproductive aging in, Front. Cell Dev. Biol., 9
  34. Roux, 2023, Individual cell types in C. elegans age differently and activate distinct cell-protective responses, Cell Rep., 42, 10.1016/j.celrep.2023.112902 · DOI
  35. Edwards, 2015, Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans, BMC Genet., 16, 8, 10.1186/s12863-015-0167-2 · DOI
  36. Rollins, 2017, Assessing health span in caenorhabditis elegans: lessons from short-lived mutants, J Gerontol A Biol Sci Med Sci, 72, 473, 10.1093/gerona/glw248 · DOI
  37. Bansal, 2015, Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants, Proc. Natl. Acad. Sci. U. S. A, 112, E277, 10.1073/pnas.1412192112 · DOI · Paper page
  38. Mouchiroud, 2011, Pyruvate imbalance mediates metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans, Aging Cell, 10, 39, 10.1111/j.1474-9726.2010.00640.x · DOI
  39. Tauffenberger, 2019, Lactate and pyruvate promote oxidative stress resistance through hormetic ROS signaling, Cell Death Dis., 10, 653, 10.1038/s41419-019-1877-6 · DOI
  40. Dhondt, 2021, Prediction of biological age by morphological staging of sarcopenia in Caenorhabditis elegans, Dis. Model. Mech., 14, 10.1242/dmm.049169 · DOI
  41. Culbertson, 2010, Effects of beta-alanine on muscle carnosine and exercise performance: a review of the current literature, Nutrients, 2, 75, 10.3390/nu2010075 · DOI
  42. Kohen, 1988, Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain, Proc. Natl. Acad. Sci. U. S. A., 85, 3175, 10.1073/pnas.85.9.3175 · DOI · Paper page
  43. Rambold, 2011, Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation, Proc. Natl. Acad. Sci. U. S. A, 108, 10190, 10.1073/pnas.1107402108 · DOI
  44. Mavaddatiyan, 2025, Exploring the association between aging, ferroptosis, and common age-related diseases, Arch. Gerontol. Geriatr., 135, 10.1016/j.archger.2025.105877 · DOI
  45. Barritt, 2024, Coenzyme A biosynthesis: mechanisms of regulation, function and disease, Nat. Metab., 6, 1008, 10.1038/s42255-024-01059-y · DOI
  46. Palmer, 1968, Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XIV. Location of the sites of inhibition of rotenone, barbiturates, and piericidin by means of electron paramagnetic resonance spectroscopy, J. Biol. Chem., 243, 844, 10.1016/S0021-9258(19)81742-8 · DOI · Paper page
  47. Sukumar, 2019, Paraquat: the poison potion, Indian J. Crit. Care Med., 23, S263
  48. Baskoylu, 2018, Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration, PLoS Genet., 14, 10.1371/journal.pgen.1007682 · DOI
  49. Park, 2007, Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model, Neurosci. Lett., 413, 265, 10.1016/j.neulet.2006.11.058 · DOI
  50. Hewitt, 2018, Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of, Dis. Model. Mech., 11
  51. De Paepe, 2023, What nutraceuticals can Do for Duchenne muscular dystrophy: lessons learned from amino acid supplementation in mouse models, Biomedicines, 11, 10.3390/biomedicines11072033 · DOI
  52. Tribble, 2023, NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve, Acta Neuropathol Commun, 11, 18, 10.1186/s40478-023-01513-0 · DOI
  53. Stringer, 2021, Cellpose: a generalist algorithm for cellular segmentation, Nat. Methods, 18, 100, 10.1038/s41592-020-01018-x · DOI · Paper page
  54. Bankhead, 2017, QuPath: open source software for digital pathology image analysis, Sci. Rep., 7, 10.1038/s41598-017-17204-5 · DOI · Paper page
  55. Beydoun, 2021, An alternative food source for metabolism and longevity studies in Caenorhabditis elegans, Commun. Biol., 4, 258, 10.1038/s42003-021-01764-4 · DOI

Metadata

Authors
Jonk, S. M., Nicol, A., Chrysostomou, V., Lardner, E., Yu, S.-C., Stålhammar, G., Crowston, J. G., Tribble, J. R., Swoboda, P., & Williams, P. A.
Affiliations
  • Karolinska Institutet (SE)
  • National University of Singapore (SG)
  • The University of Sydney (AU)
Corresponding author
Williams, Pete A.
Venue
Redox Biology
Publisher
Elsevier BV
Published
2025-09
Volume
85
Pages
103732
ISSN
2213-2317 (ISSN-L)
OpenAlex
W4411302192
Cited by
6
References
2
Citations by year
2026: 4 · 2025: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • Redox Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • S:t Eriks Ögonforskningsstiftelse
  • Swedish Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords
sarcopenia, skeletal muscle aging, muscle metabolomics, longevity, healthspan, beta-alanine, 4-hydroxyproline, pantothenic acid, mitochondrial protection, amyotrophic lateral sclerosis, Duchenne muscular dystrophy, neurodegeneration, DNA damage
MeSH terms
Aging, Animals, Longevity, Mice, Inbred C57BL, Caenorhabditis elegans, Muscle, Skeletal, Mice, Metabolomics, Metabolome, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review